Back to the catalogue
Retatrutide research product vial

Retatrutide research product

10mg vial, research use only

NZD

The Retatrutide research product is available in New Zealand for laboratory study.

Retatrutide (LY3437943) is a novel long-acting peptide agonist targeting three incretin-related receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Developed by Eli Lilly, it is the first triple agonist of its class to enter advanced clinical investigation.The molecule features a 39-amino-acid sequence with a C20 fatty diacid moiety enabling albumin binding and extended half-life. Laboratory research has investigated its simultaneous activation of GLP-1R, GIPR, and GCGR signaling cascades, examining differential cAMP accumulation, beta-arrestin recruitment, and receptor internalization kinetics across all three receptor subtypes. In-vitro studies have characterized its binding affinity profile, with reported EC50 values in the picomolar to low nanomolar range across target receptors.Molecular Weight: 4,731.33 g/mol. Appearance: White lyophilized powder. Solubility: Soluble in water. Storage: -20°C, lyophilized, sealed and protected from light. Handle with care — avoid vigorous shaking.

Quantity
1
≥99% purity, COA available
Cold-chain packed
Tracked NZ courier

About this research peptide

Every peptide in our catalogue is supplied as a lyophilised (freeze-dried) powder in a sealed vial, accompanied by a batch number for full traceability. Before release, each batch is analysed by high-performance liquid chromatography (HPLC) to confirm ≥99% purity and by mass spectrometry (MS) to verify sequence identity. A batch-specific Certificate of Analysis is available on request.

For laboratory use, reconstitute the lyophilised peptide using bacteriostatic water or the solvent specified by your research protocol. Store lyophilised vials at −20°C, protected from light and moisture, and keep reconstituted solutions refrigerated at 2–8°C. Always follow your institution’s laboratory safety procedures and handle these compounds in accordance with all applicable New Zealand regulations.

These products are supplied strictly for in-vitro laboratory research purposes only. They are not medicines or dietary supplements, are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.

All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.

Loading reviews…

Koru Research Peptides

Quality core research peptides at competitive New Zealand prices. Every batch is independently tested and supplied with a Certificate of Analysis.

All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.

Support

© 2026 Koru Research Peptides. All rights reserved.

Prices in NZD. Secure encrypted checkout.